333 related articles for article (PubMed ID: 18041664)
1. Smoking behavior and related cancers: the role of CYP2A6 polymorphisms.
Nakajima M
Curr Opin Mol Ther; 2007 Dec; 9(6):538-44. PubMed ID: 18041664
[TBL] [Abstract][Full Text] [Related]
2. Implications of CYP2A6 genetic variation for smoking behaviors and nicotine dependence.
Malaiyandi V; Sellers EM; Tyndale RF
Clin Pharmacol Ther; 2005 Mar; 77(3):145-58. PubMed ID: 15735609
[TBL] [Abstract][Full Text] [Related]
3. Interindividual differences in nicotine metabolism and genetic polymorphisms of human CYP2A6.
Nakajima M; Kuroiwa Y; Yokoi T
Drug Metab Rev; 2002 Nov; 34(4):865-77. PubMed ID: 12487152
[TBL] [Abstract][Full Text] [Related]
4. A common genetic defect in nicotine metabolism decreases risk for dependence and lowers cigarette consumption.
Tyndale RF; Pianezza ML; Sellers EM
Nicotine Tob Res; 1999; 1 Suppl 2():S63-7; discussion S69-70. PubMed ID: 11768189
[TBL] [Abstract][Full Text] [Related]
5. Nicotine metabolism defect reduces smoking.
Pianezza ML; Sellers EM; Tyndale RF
Nature; 1998 Jun; 393(6687):750. PubMed ID: 9655391
[No Abstract] [Full Text] [Related]
6. The role of CYP2A6 in the emergence of nicotine dependence in adolescents.
Audrain-McGovern J; Al Koudsi N; Rodriguez D; Wileyto EP; Shields PG; Tyndale RF
Pediatrics; 2007 Jan; 119(1):e264-74. PubMed ID: 17130279
[TBL] [Abstract][Full Text] [Related]
7. CYP2A6 genetic variation and potential consequences.
Xu C; Goodz S; Sellers EM; Tyndale RF
Adv Drug Deliv Rev; 2002 Nov; 54(10):1245-56. PubMed ID: 12406643
[TBL] [Abstract][Full Text] [Related]
8. Interindividual variability in nicotine metabolism: C-oxidation and glucuronidation.
Nakajima M; Yokoi T
Drug Metab Pharmacokinet; 2005 Aug; 20(4):227-35. PubMed ID: 16141602
[TBL] [Abstract][Full Text] [Related]
9. Genetic variability in CYP2A6 and the pharmacokinetics of nicotine.
Mwenifumbo JC; Tyndale RF
Pharmacogenomics; 2007 Oct; 8(10):1385-402. PubMed ID: 17979512
[TBL] [Abstract][Full Text] [Related]
10. Variable CYP2A6-mediated nicotine metabolism alters smoking behavior and risk.
Tyndale RF; Sellers EM
Drug Metab Dispos; 2001 Apr; 29(4 Pt 2):548-52. PubMed ID: 11259349
[TBL] [Abstract][Full Text] [Related]
11. Nicotine metabolism, human drug metabolism polymorphisms, and smoking behaviour.
Tricker AR
Toxicology; 2003 Feb; 183(1-3):151-73. PubMed ID: 12504349
[TBL] [Abstract][Full Text] [Related]
12. CYP2A6 polymorphisms are associated with nicotine dependence and influence withdrawal symptoms in smoking cessation.
Kubota T; Nakajima-Taniguchi C; Fukuda T; Funamoto M; Maeda M; Tange E; Ueki R; Kawashima K; Hara H; Fujio Y; Azuma J
Pharmacogenomics J; 2006; 6(2):115-9. PubMed ID: 16402086
[TBL] [Abstract][Full Text] [Related]
13. [Role of cytochrome P450 2A6 polymorphism in nicotine metabolism and tobacco-dependent behaviour].
Xia XY; Peng RX
Yao Xue Xue Bao; 2004 Sep; 39(9):758-63. PubMed ID: 15606031
[No Abstract] [Full Text] [Related]
14. Genetic variation in CYP2A6-mediated nicotine metabolism alters smoking behavior.
Tyndale RF; Sellers EM
Ther Drug Monit; 2002 Feb; 24(1):163-71. PubMed ID: 11805739
[TBL] [Abstract][Full Text] [Related]
15. A meta-analytic review of the CYP2A6 genotype and smoking behavior.
Carter B; Long T; Cinciripini P
Nicotine Tob Res; 2004 Apr; 6(2):221-7. PubMed ID: 15203795
[TBL] [Abstract][Full Text] [Related]
16. The genetics of nicotine dependence: relationship to pancreatic cancer.
MacLeod SL; Chowdhury P
World J Gastroenterol; 2006 Dec; 12(46):7433-9. PubMed ID: 17167830
[TBL] [Abstract][Full Text] [Related]
17. CYP2A6 gene polymorphism and personality traits for NEO-FFI on the smoking behavior of youths.
Waga C; Iwahashi K
Drug Chem Toxicol; 2007; 30(4):343-9. PubMed ID: 17934923
[TBL] [Abstract][Full Text] [Related]
18. CYP2A6 genotype and the metabolism and disposition kinetics of nicotine.
Benowitz NL; Swan GE; Jacob P; Lessov-Schlaggar CN; Tyndale RF
Clin Pharmacol Ther; 2006 Nov; 80(5):457-67. PubMed ID: 17112802
[TBL] [Abstract][Full Text] [Related]
19. Gene-gene interactions between CYP2B6 and CYP2A6 in nicotine metabolism.
Ring HZ; Valdes AM; Nishita DM; Prasad S; Jacob P; Tyndale RF; Swan GE; Benowitz NL
Pharmacogenet Genomics; 2007 Dec; 17(12):1007-15. PubMed ID: 18004205
[TBL] [Abstract][Full Text] [Related]
20. Effects of polymorphism in promoter region of human CYP2A6 gene (CYP2A6*9) on expression level of messenger ribonucleic acid and enzymatic activity in vivo and in vitro.
Yoshida R; Nakajima M; Nishimura K; Tokudome S; Kwon JT; Yokoi T
Clin Pharmacol Ther; 2003 Jul; 74(1):69-76. PubMed ID: 12844137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]